(Reuters) -Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine ...

Indian consumer firm Hindustan Unilever reported a marginal rise in third-quarter profit on Wednesday, lifted by festive ...

India's Bharat Petroleum Corp Ltd (BPCL) reported a lower-than-expected third-quarter profit on Wednesday, due to lower ...

TMC Research’s final nowcast for next week’s fourth-quarter GDP report (scheduled for release on Jan. 30) anticipates an ...

India's Paytm, on Monday, reported a narrower third-quarter adjusted loss compared with the previous quarter as its digital ...

UltraTech Cement, Dr Reddy’s Labs, Hindustan Petroleum, Mphasis, Zee, Indus Towers, Adani Green Energy, Adani Energy ...

Dr Reddy’s Laboratories reports 2% increase in net profit, attributing growth to new acquisitions and product launches.

Mankind Pharma shed 2.76% to Rs 2,560.05 after the company's consolidated net profit declined 16.2% to Rs 380.23 crore in Q3 FY25 as against Rs 453.76 crore posted in Q3 FY24.

V2 Retail hit the upper circuit of 5% at Rs 1,839.75 after the company's consolidated net profit surged 117.2% to Rs 51.19 crore in Q3 FY25 compared with Rs 23.57 crore in Q3 FY24.

IndiGo Q3 net profit is expected to see a sharp YoY fall due to costs associated with Aircraft on Ground (AoG) which have led to higher aircraft lease rentals, depreciation, and financing expenses.

IndiGo’s net profit is expected to fall 34% to ₹1,974 crore in Q3FY25 from ₹2,998.1 crore YoY. The company posted a net loss of ₹986.7 crore in the previous quarter.